Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Feb 25;11:4617. doi: 10.1038/s41598-021-84245-2

Airborne dispersion of droplets during coughing: a physical model of viral transmission

Hongying Li 1, Fong Yew Leong 1,, George Xu 1, Chang Wei Kang 1, Keng Hui Lim 1, Ban Hock Tan 2, Chian Min Loo 3
PMCID: PMC7907382  PMID: 33633316

Abstract

The Covid-19 pandemic has focused attention on airborne transmission of viruses. Using realistic air flow simulation, we model droplet dispersion from coughing and study the transmission risk related to SARS-CoV-2. Although this model defines most airborne droplets as 8–16 µm in diameter, we infer that larger droplets of 32–40 µm in diameter may potentially be more infectious due to higher viral content. Use of face masks is therefore recommended for both personal and social protection. We found social distancing effective at reducing transmission potential across all droplet sizes. However, the presence of a human body 1 m away modifies the aerodynamics so that downstream droplet dispersion is enhanced, which has implications on safe distancing in queues. At 1 m distance, we found that an average of 0.55 viral copies is inhaled for a cough at median loading, scalable up to 340 copies at peak loading. Droplet evaporation results in significant reduction in droplet counts, but airborne transmission remains possible even under low humidity conditions.

Subject terms: Health policy, Fluid dynamics

Introduction

The current coronavirus disease outbreak1 is an unprecedented global crisis with confirmed cases in the millions. The exceptional infectiousness of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused attention2 on the nature of its transmission pathways, with suspicion for an airborne route35. Airborne transmission depends on three main factors, namely, stability of virus, air circulation and droplet deposition6. SARS-CoV-2 is found to be stable in aerosol for up to the three hours of an experiment7 similar to its predecessor SARS-CoV-1 which in certain circumstances, achieved airborne transmission8. Airborne transmission of SARS-CoV-2 is now widely recognized and may explain a series of real-life, large-scale outbreaks913. Recent air sampling conducted in airborne infection isolation rooms has found PCR-positive particles of sizes in excess of 1 μm despite extensive air changes5.

During a cough or sneeze, mucosalivary fluid is expelled into the surrounding air in the form of droplets14,15. Conventionally, droplets greater than 5 μm in diameter are termed as respiratory droplets whereas those less than 5 μm in diameter are aerosols16. It should be pointed out, however, this is not a strict definition in that larger droplets can be suspended readily in air and become airborne17. The size of the droplets affects the range of dispersal significantly18. Respiratory droplets tend to settle quickly and contaminate surrounding surfaces within a short distance6,19, whereas droplet nuclei can remain airborne for hours and present a long-range transmission risk20.

As a first line of defence against the pandemic, many countries have adopted what is commonly known as ‘social distancing’ where individuals are advised, sometimes legally mandated to maintain a certain distance from other individuals in public. Mathematical models2123 suggest that enforced physical separation could be an effective measure when deployed swiftly during a viral outbreak24, based also on simulations of past viral outbreaks25. The actual recommended distance varies from 1 m (Singapore), 1.5 m (Australia), 6 feet (CDC, USA) to 2 m (UK). Generally public guidelines range from 1 to 3 m, and the ‘science behind these numbers’, as policy makers put it, is loosely based on an early seminal work26. In a recent study based on turbulent cloud physics, cough droplets are reported to spread up to 7–8 m27. Further, researchers at Wuhan hospitals found corona-virus residues in floor samples up to 4 m from identified sources28. Hence, even though the rationale behind social distancing is robust29, there is clearly no consensus as to what constitutes a safe separation distance, even for health workers treating infected patients30.

Fluid dynamics plays an important role in almost every aspect of this pandemic31. A brief survey of cough dispersion studies32 yields theoretical puff model15 and plume model33, supported by visualization techniques such as schlieren34, shadowgraph35, and particle image velocimetry36,37. Notably, numerical methods, such as Computational Fluid Dynamics (CFD) based on Reynolds Averaged Navier–Stokes (RANS) turbulence models38 produce high resolution flow fields and concentration data39, which not only compensate for slow instrumental speeds of analytical techniques32, but are also adaptable to different environments and scenarios, such as passengers in an aircraft cabin40, and more recently, a cough dispersion study in an outdoor environment under significant wind speeds41, whose results are useful in integrated transmission modeling42.

It is important to note that droplet dispersion model may infer transmissibility but not the actual infection risk. That will take an infectious dose, which refers to the number of viral particles to establish an infection in half of individuals, which depending on the type of virusx43, Risk assessment of airborne infection should also account for actual viral transport.

In this study, we performed numerical simulations of droplet dispersion from a single cough based on single person and two person settings under realistic indoor conditions and assess viral transmission through airborne droplets.

Methods

Droplet dispersion model

We consider a standing person who initiates a sudden, involuntary cough in an indoor environment. For reference we shall label the person the ‘Cougher’. Our objective here is to assess the droplet dispersion potential under representative conditions: slight breeze from behind towards the Cougher at a speed 0.3 m/s, an ambient air temperature of 25 °C and a relative humidity of 60% (typical humidity in an air-conditioned environment). The Cougher model is based on a standard human 1.7 m tall (average height for a Singaporean male) with open arms who begins normal breathing cycles immediately after the cough.

Based on established cough patterns, the standard cough is modelled as a planar jet inclined downwards at an angle 27.5° averaged between 15° and 40° angular limits of a typical cough jet44. The mouth opening area is 4 cm2, a time-averaged value based on mouth opening data during a cough44. The cough emits a cluster of droplets with standard size distribution15,46 and viral loading47. Based on cough tests39,43, the modelled velocity profile reaches peak 10 m/s at 0.1 s and decays to zero at 0.5 s46. At the end of the cough cycle, breathing cycle begins, modelled here as a sinusoidal function with a period of 6 s and amplitude of 0.73 m/s46. Accordingly, characteristic Reynolds numbers for cough is approximately 13,000 and for normal breath 1000. Breath temperature is assumed to be 36 °C.

Separately, we consider the case of two persons, with the other labelled the ‘Listener’. The Listener model, positioned either 1 or 2 m away from the Cougher, is based on a standard human 1.59 m tall (average height for a Singaporean female) with arms closed and she begins normal breathing cycles immediately at the start of the cough.

Using Eulerian–Lagrangian model, we solve numerically for Newtonian air flow, temperature, species and droplet trajectories in space and time, using finite volume method implemented on ANSYS FLUENT (2019R3). First, steady state Eulerian simulations with species transport are performed for humid air flow and heat transport within the domain. Then using steady state solutions as input, simulations are repeated using discrete phase model, where transient momentum and heat transfer are included in Lagrangian tracking of droplet trajectories. Droplets are assumed stable and do not experience breakup due to the low We number (maximum We number is 1.7). The governing equations and computational details can be found in the Supplementary Information.

Viral transmission analysis

We collect all droplets past designated distances, specifically 0.5, 1.0, 1.5 and 2.0 m from the source and characterize their respective size distributions time-averaged up to 10 s since the onset of the cough and adjusted for wind speed (0.3 m/s). The droplet count probability is a probability function obtained by taking the ratio of the number of droplets of a certain size and the width of the corresponding size interval based on the original size histogram45. To assess viral transmission potential, we calculate the number of viral copies found in each droplet in terms of the viral load (copies per volume). The median viral count probability is a probability distribution obtained by taking the product of median SARS-CoV-2 viral load (3.3 × 106 copies/mL)47 and the droplet count probability distribution. The day-0 viral load sampled from patients on admission day is 5.7 × 107 copies/mL47. More recent data reported similar viral loads, with average load of 7.0 × 106 copies/mL and peak load of 2.35 × 109 copies/mL48. The viral loading found in saliva is assumed to be homogeneously distributed among droplets emitted during a cough49.

Risk assessment

To assess the extent of exposure, we collect droplets deposited on the Listener model surfaces, over the entire body (surface area 1.43 m2) and the mouth region (3.5 cm2), assuming mouth breathing, and including normal breathing cycles. Separately, we include a scenario where the Listener is wearing a mask (aspect ratio 1.43) and account for droplets landing on the mask (288 cm2). The droplet deposition count probability is a probability function obtained by taking the ratio of the number of deposited droplets of a certain size and the interval of that size based on the original size histogram45. The median viral deposition count probability is a probability distribution obtained by taking the product of median SARS-CoV-2 viral load (3.3 × 106 copies/mL)47 and the droplet deposition count probability distribution. Total deposited viral counts are obtained by integrating the respective median viral count probability distributions within size distribution limits (2–100 µm). Pulmonary deposition efficiency is not considered, since all droplets are in micron size range and do not escape readily via exhalationx50. In addition, we do not distinguish between exposure to ingested or inhaled droplets, and trapped droplets do not re-entrain.

Results

Droplet dispersion

For the base case with a single Cougher, Fig. 1 shows snapshots of 2–100 µm droplet dispersion up to 10 s following a cough, side and top-down view, without (top) and with evaporation physics (bottom). Generally, larger droplets (in red) separate from the cloud and settle in seconds with a dispersion range of barely 1 m; smaller droplets (in blue) are buoyant and spread over large distances but may also evaporate rapidly into residues known as droplet nuclei26. For non-evaporative case (Fig. 1; top), the droplet cloud starts off as a fast moving puff15 from the oral region but quickly disperses into a plume33 inclined at an angle from 14° to 10° (10 s) from the chest. Top-down view shows that the lateral droplet dispersion in depth is relatively constant, and by inspection, the plume can be effectively confined within a 20° forward wedge. Droplets near the sides of the virtual wedge travel faster than those near the center due to entrainment of air flow into the wake.

Figure 1.

Figure 1

Droplet dispersion (side and top-down views) from a single cough inclined downwards at 27.5° for non-evaporative (top) and evaporative (bottom) cases at relative humidity of 60%. Color bar indicates droplet sizes (2–100 µm). Vertical lines are spaced 1 m apart and arrows are drift markers based on a background wind speed of 0.3 m/s. Ambient air temperature is 25 °C and breath temperature is 36 °C. Plume angles 14–10° from the chest 10 s after the cough and lateral dispersion fits a 20° forward wedge.

For the evaporative case, significant reduction in droplet counts is observed seconds from the cough (Fig. 1; bottom). At relative humidity of 60%, the lifetime of a droplet 10–100 µm is in the order of seconds (Supplementary Figure S1). Small droplets rapidly evaporate into droplet nuclei, which continue to remain airborne for a long time due to their small size. As evaporating droplets decrease in size, the settling times are increased, resulting in a horizontal plume at hip level. Droplets are also observed to become more mono-disperse (a decrease in diversity of droplet sizes) compared to non-evaporative case. Top-down view shows minimal lateral dispersion for the remaining droplets. Taking the 20° forward wedge plume from the non-evaporative case, it is likely that evaporated droplets, or droplet nuclei, would follow similar dispersion trends.

At very short distances from the cough (< 0.2 m), the central velocity is higher due to the cough jet stream being greater than the surrounding air velocity51,52. However, this study concerns the long-range dispersion of droplets partly propelled by the wind. Since the wind is coming from behind the cougher, there is a velocity deficit in the wake, such that the edge velocity is higher than the center. This results in the dispersion profile as shown in Fig. 1.

The droplet count probability depends on the droplet size distribution and distance from the Cougher (Fig. 2). The mode of the distribution lies between 8 and 16 µm; closer to 8 µm at short distances (< 1 m) but closer to 16 µm at longer distances. Increase in distance results in reduction of droplet counts across all droplet sizes. Interestingly, we find that droplets between 32 and 40 µm represent the highest transmission potential in terms of droplet sizes. Fewer in numbers compared to 8–16 µm droplets, these 32–40 µm droplets contain much higher viral counts due to their larger volumes. Larger droplets greater than 75 µm contain even higher viral count per droplet, but they tend to settle rapidly and therefore present little airborne transmission potential except under strong wind conditions41.

Figure 2.

Figure 2

Airborne droplets with horizontal distances exceeding indicated distances from source, time-averaged up to 10 s since onset of cough, adjusted for wind drift (0.3 m/s). (A) Droplet count probability. Mode: 8–16 µm. (B) Median viral count probability based on median viral load (3.3 × 106 copies/mL)46. Mode: 32–40 µm. Droplets larger than 75 µm have low airborne transmission potential despite high viral counts.

Exposure to virus via droplets depends on distancing, as well as wind speed and direction (Fig. 3). For 0.5 m distancing without evaporation, the median viral count accumulates rapidly to 80 in less than 1 s due to high velocity droplet transport from the cough jet, which is substantially faster than the background wind drift. Between 5 to 9 s, viral counts are elevated from 100 copies up to 147 due to the passage of a cloud of large droplets drifting close to the ground before settling (Fig. 3; 5–7.5 s); these droplets contain high viral counts. As distancing increases, the droplets become more wind dispersed, in this case, at a wind speed of 0.3 m/s. In particular, it takes approximately 7 s for viruses to be projected over a distance of 2 m. This delay may provide sufficient time for simple reactive measures, such as stepping away or wearing a surgical mask.

Figure 3.

Figure 3

Median viral count collected at indicated distances from source in time, for cases (A) without evaporation and (B) with evaporation at relative humidity of 60%. Evaporated droplets persist as droplet nuclei which may pose infection risk over extended distance and time scales. Vertical lines along the abscissa denote the time required for wind drift to cover the indicated distance (m).

For the evaporative case with 0.5 m distancing, the median viral count accumulates rapidly to 70, then decreases as smaller droplets with lifetimes under 1 s evaporate into nuclei. Between 4.5 to 8 s, viral count increases from 33 copies up to 121 also due to the passage of a cloud of large droplets drifting close to the ground. Compared to the non-evaporative case, this increase is more significant, because large droplets tend to evaporate slowly compared to small ones (Supplementary Information), and as droplet lifetimes are increased as they shrink in size and they remain airborne for longer periods of time. In addition, the non-volatile components are conserved, so the viral loads (in copies per unit volume) in evaporating droplets are higher than the original viral loads released from the source. Upon complete droplet evaporation, viruses persist in the dry residue as airborne nuclei, which continue to pose infection risks over extended distance and time. Here, the viral counts shown in Fig. 3 represents droplet transmission and excludes viruses contained in airborne nuclei.

The number of viral copies required to establish an infection in half of individuals, or Infectious Dose (ID), is wide-ranging and depends significantly on the type of virus. The ID for SARS-CoV-2 is currently unknown but expected to be small, based on how fast the virus has spread globally. Since the viral load sampled from patients on admission day (day-0) is more than 17 times the median load47, reading off at a rescaled viral dose of ~ 6 (100/17) would suggest significant infection probabilities.

Two persons separated by 1 m

For 1 m distancing, Fig. 4 shows snapshots of 2–100 µm droplet dispersion up to 10 s following a cough, side and top-down view, without (top) and with evaporation (bottom). With a Listener model as an obstacle to air flow, the aerodynamics is modified so that the droplet plume is elevated and its angle is now horizontal from the Cougher’s chest level up to 10 s following the cough. The presence of the Listener at 1 m has effectively increased the dispersion range of the droplet plume, with practical consequences. Observe that the head of the Listener is engulfed by the droplet plume when it should not be at that distance (Fig. 1). Also, now since air has to move around the Listener, the lateral dispersion length is now defined by the characteristic width of the Listener (shoulder to shoulder), which by inspection, results in a 30° wedge, instead of the 20° wedge previously obtained for single Cougher case (Fig. 1). Further downstream, the lateral plume angle is horizontal and as before, the droplets further from the center travel faster than those near the center due to entrainment of air in the Listener’s wake.

Figure 4.

Figure 4

Droplet dispersion (side and top-down views) from a single cough inclined downwards at 27.5° for non-evaporative (top) and evaporative (bottom) cases at relative humidity of 60%. Listener is 1 m away facing Cougher. Color bar indicates droplet sizes (2–100 µm). Arrows represent drift markers based on a background wind speed of 0.3 m/s. Ambient air temperature is 25 °C and breath temperature is 36 °C. Plume is aligned horizontally from the chest up to 10 s after the cough and lateral dispersion fit a 30° forward wedge.

For the evaporative case, significant reduction in droplet counts is observed seconds from the cough (Fig. 4). Unlike the non-evaporative case, the dispersion of evaporating droplets is found to be relatively unaffected by the presence of the Listener. Dispersion of droplet nuclei is expected to follow air streamlines due to their small sizes.

Figure 5 shows the air flow field with Listener 1 m away at 0.1 and 5.0 s from the cough. At the mouth level, the velocity field is initially dominated by the high velocity air jet from the cough. Both the width of the cough jet and the decay of jet speed fall within expected ranges reported in experimentally measured cough profiles53. At the waist level, the flow field is unaffected by the cough jet.

Figure 5.

Figure 5

Velocity fields between a Cougher and a Listener spaced 1 m apart at 0.1 and 5 s following a single cough inclined downwards at 27.5°. Color bar indicates velocity magnitude. Top panels: side view (center plane); middle panels: top-down view (cross-section at Cougher mouth level); Bottom panels: top-down view (cross-section at Cougher waist level) reveals steady flow fields.

Two persons separated by 2 m

For 2 m distancing, Fig. 6 shows droplet dispersion up to 10 s following a cough, for both side and top-down views, without (top) and with evaporation (bottom). With the Listener now further away, the droplet plume reverts to the base case scenario (Fig. 1), where it is inclined from 14° to 10° from the chest level of the Cougher up to 10 s. Closer to the Listener, however, the plume realigns horizontally as air wraps around the chest level. Top-down view shows that the lateral plume is now confined within a 20° forward wedge (instead of 30° for 1 m distancing), since the width of the Listener is smaller than the characteristic width of the wake at that distance. The chest presents a wider obstacle to droplet dispersion compared to the head (Fig. 1), resulting in a droplet-free wake further downstream from the Listener. For the evaporative case, the dispersion of evaporating droplets is similarly unaffected by the Listener at 2 m.

Figure 6.

Figure 6

Droplet dispersion (side and top-down views) from a single cough inclined downwards at 27.5° for non-evaporative (top) and evaporative (bottom) cases at relative humidity of 60%. Listener is 2 m away facing Cougher. Color bar indicates droplet sizes (2–100 µm). Vertical lines are spaced 1 m apart and arrows are drift markers based on a background wind speed of 0.3 m/s. Ambient air temperature is 25 °C and breath temperature is 36 °C. Plume angles 14–10° from the chest level and lateral dispersion fits a 20° forward wedge.

Droplet deposition and viral transmission

Figure 7 shows that most of the droplets deposit on the body surface, and only a small fraction on the mouth region, which are inhaled or ingested. The modes for body deposition are 8–16 µm at 1 m and 16–24 µm at 2 m; the average mode for mouth and mask deposition is 4–8 µm at both distancing. Although the number of droplets deposited on the mouth (inhaled) is less than on the body, the deposition efficiency (per unit area) is substantial since the surface area of the mouth region is only 0.02% of the entire body. The droplet Stokes number ranges from 10–6 for 2 µm droplet to 0.002 for 100 µm droplet.

Figure 7.

Figure 7

Droplet and virus deposition on the surfaces of the Listener model, including body (1.43 m2), mouth (3.5 cm2) and mask (288 cm2). (A) Droplet deposition count probability. Modes: 8–16 µm (body; 1 m), 16–24 µm (body; 2 m) and 4–8 µm (mouth/mask). (B) Median viral deposition count probability (3.3 × 106 copies/mL)46. Modes: 32–40 µm (body; 1 m) and 24–32 µm (body; 2 m). Inset shows viral deposition count probabilities for mouth and mask. Mode: 16–24 µm (mouth/mask; 1 m). For 1 m distancing, the total deposited viral counts on the Listener model are 25.3 (body), 0.55 (mouth) and 0.72 (mask).

During the inhalation half cycle, droplets are transported by the air intake into the mouth where they may be ingested, inhaled or exhaled. Droplet deposition on the mask is enhanced due to breathing cycles. Inhaled droplets are generally smaller (mode: 4–8 µm) in size compared to those deposited on the Listener’s body (mode: 8–24).

The median viral deposition count probability based on SARS-CoV-2 viral load (3.3 × 106 copies/mL)46 shows significant viral deposition on the body surface (Fig. 7). Interestingly, the highest viral counts found on the body are deposited by droplets of sizes 32–40 µm at 1 m and 24–32 µm at 2 m, which is the opposite trend for droplet counts (8–16 µm at 1 m; 16–24 µm at 2 m). This is because large droplets 32–75 µm settle preferentially at distance 1–2 m, leading to significant reductions in viral counts. Total deposited viral counts are 25.3 viral copies on the Listener’s body, 0.72 on mask, and 0.55 on mouth (inhaled). The projected inhalation exposure increases to 9.3 copies for day-0 viral load (5.7 × 107 copies/mL)47, up to 390 copies at peak loading (2.35 × 109 copies/mL)48. Increasing distancing to 2 m results in significant reductions in viral deposition counts on the body and transmission risks from droplet inhalation.

Discussion and conclusion

Young children may be at greater risk from droplet transmission compared to adults (Fig. 1). Inspection of the droplet plume shows maximum droplet count densities at characteristic heights at 1.2 m for 1 m distancing, and 1.0 m for 2 m. A useful guideline for height-related risk would be within a height difference of 50 cm at a distance of 1 m, and 70 cm a distance of 2 m, depending on the height of the Cougher.

In this model, we define airborne droplets as 8–16 µm in diameter, and droplets as 32–40 µm in diameter, which may potentially be more infectious due to higher viral content (Fig. 2). Nevertheless, we point out that aerosol sampling studies have reported more viral copies collected from fine particles (< 5 µm) than coarse (> 5 µm) ones, so droplet size alone may not be the best indicator of airborne viral infectiousness54,55, and several studies have shown that viral copy numbers may be higher in smaller particles, such as aerosols56. Surgical masks are known to be effective at trapping these larger droplets, so they are recommended for use as necessary55. However, it is important to note that the loose-fitting surgical masks (i.e. they are not fit-tested) are less effective at protecting the wearer from aerosols because they can be inhaled from around the side of the mask, rather than the mask failing to capture them directly57.

Our results suggest that social distancing is generally effective at reducing droplet counts across all droplet sizes. Specifically, an increase in distancing from 0.5 to 1 m significantly reduces potential exposure to large droplets greater than 75 µm, and further increase in distancing to 2 m further halves the transmission potential across all droplet sizes. Understanding the infectious dose of SARS-CoV-2 is essential to quantitative risk assessment.

Under low humidity conditions, small droplets evaporate rapidly in a fraction of a second, whereas moderately large droplets can persist over a few seconds and remain airborne (Fig. 3). Evaporated droplet residues, or nuclei, contain high viral densities and present long ranged airborne transmission risks. Smaller and lighter, these droplet nuclei contain viral residues in a compact form and could remain airborne for long period of time, projecting transmission risks over long distances. The effect of desiccation on the viability of SARS-CoV-2 found in droplet nuclei is currently not well understood.

Interesting aerodynamics come into play when a person obstructs the airflow downstream from the cough (Fig. 4). Counter-intuitively, the person being 1 m away from the cough may not only fail to obstruct the plume itself, but instead enhance its dispersion range further downstream. This suggests that a 1 m distancing rule between individuals in a queue may have adverse consequences.

The airflow result for 1 m distancing also has practical consequences for face shield users. Based on our modelling results, the droplet plume for a person at 1 m follows the air flow over the chest (Fig. 5), so the droplets reach the face region from a bottom-up direction which circumvents the face shield. Therefore, the face shield may be ineffective as a protection against droplets based on aerodynamic considerations. An improvement to the face shield design could be a chin plate that prevents air flow from the chest upwards; air could instead be drawn in from the back of the head around the sides.

Based on median viral load, an average of 0.55 viral copies is inhaled 1 m away from a single cough. This result could still be amplified through successive coughs at higher viral loads (day-0 or peak) and accumulated over time. Other air sampling studies5860 have reported comparable viral counts, accounting for sampling times and flowrates. Droplets deposited on skin and clothes could still lead to secondary transmission modes such as face touching.

The present study has several limitations. First, the cough model is idealized. The droplet size distribution is based on 22 cough tests and measurements of some 3,000 droplets captured on slides44 and the cough airflow based on 25 test subjects44. These sources, while representative, do not account for significant variations in coughing intensity and duration61s, droplets emitted through vocalization and sneezes are not considered in this study. Third, the height of the Cougher can affect the dispersive range of droplets, especially larger droplets which tend to settle rapidly on emission. This effectively increases the droplet transmission potential from taller infected persons. Fourth, a light prevailing wind with constant speed is assumed for indoor conditions, but wind speed significantly affects the dispersion range of droplet. Under outdoor conditions, wind speeds can reach up to several meters per second, leading to dispersion ranges that exceed currently accepted social distances even under strongly evaporative conditions41. Fifth, this study does not distinguish between viable and non-viable viruses, only viral count and load. Sixth, the evaporation physics used here is based on weak coupling between droplets, so droplets evaporate rapidly into smaller droplet nuclei which persists airborne. Droplet evaporation with non-volatile content is included in separate study46.

From our data, we conjecture that the concept of “airborne” or “droplet” transmission as applied to a respiratory pathogen may be relative. Physical factors, such as wind speed and direction, interact with biological ones, such as infectious dose, to determine the likelihood with which the coughing sick infect others in their immediate vicinity.

Supplementary Information

Supplementary Information (663.4KB, docx)

Author contributions

H.Y.L. and G.X. ran the simulations. F.Y.L. and H.Y.L. wrote the manuscript. F.Y.L. interpreted and organized data. C.W.K. and K.H.L. initiated and designed the study. B.H.T. and C.M.L. advised the study and proofread the manuscript. All authors reviewed the manuscript.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-021-84245-2.

References

  • 1.Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Asadi S, Bouvier N, Wexler AS, Ristenpart WD. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol Sci. Technol. 2020;54(6):635–638. doi: 10.1080/02786826.2020.1749229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Peng X, et al. Transmission routes of 2019-nCoV and controls in dental practice. Int. J. Oral Sci. 2020;12(1):1–6. doi: 10.1038/s41368-020-0075-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environ. Int. 2020;139:105730. doi: 10.1016/j.envint.2020.105730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chia PY, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun. 2020;11(1):1–7. doi: 10.1038/s41467-020-16670-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pica N, Bouvier NM. Environmental factors affecting the transmission of respiratory viruses. Curr. Opin. Virol. 2012;2(1):90–95. doi: 10.1016/j.coviro.2011.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Van Doremalen N, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020;382(16):1564–1567. doi: 10.1056/NEJMc2004973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Booth TF, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J. Infect. Dis. 2005;191(9):1472–1477. doi: 10.1086/429634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shen Y, et al. Community outbreak investigation of SARS-CoV-2 transmission among bus riders in eastern China. JAMA. 2020 doi: 10.1001/jamainternmed.2020.5225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lu J, et al. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg. Infect. Dis. 2020;26(7):1628–1631. doi: 10.3201/eid2607.200764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hamner L, et al. High SARS-CoV-2 attack rate following exposure at a choir practice—Skagit County, Washington, March 2020. Morbid. Mortal Wkly Rep. 2020;69(19):606–610. doi: 10.15585/mmwr.mm6919e6. [DOI] [PubMed] [Google Scholar]
  • 12.Miller SL, et al. Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event. Indoor Air. 2020 doi: 10.1111/ina.12751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Park SY, et al. Coronavirus disease outbreak in call center South Korea. Emerg. Infect. Dis. 2020;26(7):1666–1670. doi: 10.3201/eid2608.201274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lindsley WG, Reynolds JS, Szalajda JV, Noti JD, Beezhold DH. A cough aerosol simulator for the study of disease transmission by human cough-generated aerosols. Aerosol Sci. Technol. 2013;47(8):937–944. doi: 10.1080/02786826.2013.803019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bourouiba L, Dehandschoewercker E, Bush JW. Violent expiratory events: on coughing and sneezing. J. Fluid Mech. 2014;745:537–563. doi: 10.1017/jfm.2014.88. [DOI] [Google Scholar]
  • 16.Chartier Y, Pessoa-Silva CL. Natural Ventilation for Infection Control in Health-Care Settings. Geneva: World Health Organization; 2009. [PubMed] [Google Scholar]
  • 17.Milton DK. A rosetta stone for understanding infectious drops and aerosols. J. Pediat. Inf. Dis Soc. 2020;9(4):413–415. doi: 10.1093/jpids/piaa079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tellier R, Li Y, Cowling BJ, Tang JW. Recognition of aerosol transmission of infectious agents: A commentary. BMC Infect. Dis. 2019;19(1):101. doi: 10.1186/s12879-019-3707-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kutter JS, Spronken MI, Fraaij PL, Fouchier RA, Herfst S. Transmission routes of respiratory viruses among humans. Curr. Opin. Virol. 2018;28:142–151. doi: 10.1016/j.coviro.2018.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fernstrom A, Goldblatt M. Aerobiology and its role in the transmission of infectious diseases. J. Pathog. 2013 doi: 10.1155/2013/493960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ferguson, N. et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand (Imperial College COVID-19 Response Team, March 16 2020). [DOI] [PMC free article] [PubMed]
  • 22.Huang J, et al. Optimal temperature zone for the dispersal of COVID-19. Sci. Total Environ. 2020 doi: 10.1016/j.scitotenv.2020.139487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Huang J, et al. Global prediction system for COVID-19 pandemic. Sci. Bull. 2020 doi: 10.1016/j.scib.2020.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Koo JR, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: A modelling study. Lancet. Infect. Dis. 2020;20(6):678–688. doi: 10.1016/S1473-3099(20)30162-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kelso JK, Milne GJ, Kelly H. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health. 2009;9(1):117. doi: 10.1186/1471-2458-9-117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wells WF. On air-borne infection: Study II. Droplets and droplet nuclei. Am. J. Epidemiol. 1934;20(3):611–618. doi: 10.1093/oxfordjournals.aje.a118097. [DOI] [Google Scholar]
  • 27.Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: Potential implications for reducing transmission of COVID-19. JAMA. 2020;323(18):1837–1838. doi: 10.1001/jama.2020.4756. [DOI] [PubMed] [Google Scholar]
  • 28.Guo Z, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China. Emerg. Infect. Dis. 2020;26(7):1583–1591. doi: 10.3201/eid2607.200885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sen-Crowe B, McKenney M, Elkbuli A. Social distancing during the COVID-19 pandemic: Staying home save lives. Am. J. Emerg. Med. 2020;38:1515–1539. doi: 10.1016/j.ajem.2020.01.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bahl P, et al. Airborne or droplet precautions for health workers treating coronavirus disease 2019? J. Infect. Dis. 2020 doi: 10.1093/infdis/jiaa189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mittal R, Ni R, Seo J. The flow physics of COVID-19. J. Fluid Mech. 2020;894:F2. doi: 10.1017/jfm.2020.330. [DOI] [Google Scholar]
  • 32.Ai ZT, Melikov AK. Airborne spread of expiratory droplet nuclei between the occupants of indoor environments: A review. Indoor Air. 2018;28(4):500–524. doi: 10.1111/ina.12465. [DOI] [PubMed] [Google Scholar]
  • 33.Wei J, Li Y. Enhanced spread of expiratory droplets by turbulence in a cough jet. Build. Environ. 2015;93:86–96. doi: 10.1016/j.buildenv.2015.06.018. [DOI] [Google Scholar]
  • 34.Tang JW, Liebner TJ, Craven BA, Settles GS. A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J. R. Soc. Interface. 2009;6(6):S727–736. doi: 10.1098/rsif.2009.0295.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tang JW, et al. Airflow dynamics of coughing in healthy human volunteers by shadowgraph imaging: An aid to aerosol infection control. PLoS ONE. 2012;7(4):e34818. doi: 10.1371/journal.pone.0034818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.VanSciver M, Miller S, Hertzberg J. Particle image velocimetry of human cough. Aerosol Sci. Technol. 2011;45(3):415–422. doi: 10.1080/02786826.2010.542785. [DOI] [Google Scholar]
  • 37.Zhu S, Kato S, Yang JH. Study on transport characteristics of saliva droplets produced by coughing in a calm indoor environment. Build. Environ. 2006;41(12):1691–1702. doi: 10.1016/j.buildenv.2005.06.024. [DOI] [Google Scholar]
  • 38.Fluent AN. 13.0 Theory guide, turbulence. ANSYS Inc. 2010.
  • 39.Nielsen PV. Fifty years of CFD for room air distribution. Build. Environ. 2015;91:78–90. doi: 10.1016/j.buildenv.2015.02.035. [DOI] [Google Scholar]
  • 40.Yang L, Li X, Yan Y, Tu J. Effects of cough-jet on airflow and contaminant transport in an airliner cabin section. J. Comput. Multiphase Flows. 2018;10(2):72–82. doi: 10.1177/1757482X17746920. [DOI] [Google Scholar]
  • 41.Dbouk T, Drikakis D. On coughing and airborne droplet transmission to humans. Phys. Fluids. 2020;32(5):053310. doi: 10.1063/5.0011960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chaudhuri S, Basu S, Kabi P, Unni VR, Saha A. Modeling the role of respiratory droplets in Covid-19 type pandemics. Phys. Fluids. 2020;32(6):063309. doi: 10.1063/5.0015984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Atmar RL, et al. Determination of the 50% human infectious dose for Norwalk virus. J. Infect. Dis. 2014;209(7):1016–1022. doi: 10.1093/infdis/jit620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gupta JK, Lin CH, Chen Q. Flow dynamics and characterization of a cough. Indoor Air. 2009;19(6):517–525. doi: 10.1111/j.1600-0668.2009.00619.x. [DOI] [PubMed] [Google Scholar]
  • 45.Duguid JP. The size and the duration of air-carriage of respiratory droplets and droplet-nuclei. Epidemiol. Infect. 1946;44(6):471–479. doi: 10.1017/S0022172400019288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Li H, et al. Dispersion of evaporating cough droplets in tropical outdoor environment. Phys. Fluids. 2020;32:113301. doi: 10.1063/5.0026360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.To KK, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wӧlfel R, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. doi: 10.1038/s41586-020-2196-x. [DOI] [PubMed] [Google Scholar]
  • 49.Basu S. Close-range exposure to a COVID-19 carrier: transmission trends in the respiratory tract and estimation of infectious dose. medRxiv. 2020 doi: 10.1101/2020.07.27.20162362. [DOI] [Google Scholar]
  • 50.Darquenne C. Aerosol deposition in health and disease. J. Aerosol Med. Pulmonary Drug Deliv. 2012;25(3):140–147. doi: 10.1089/jamp.2011.0916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Tang JW, Settles GS. Coughing and aerosols. N. Engl. J. Med. 2008;359:e19. doi: 10.1056/NEJMicm072576. [DOI] [PubMed] [Google Scholar]
  • 52.Tang JW, Liebner TJ, Crazen BA, Settles GS. A schlieren optical study of the human cough with and without wearing masks for aerosol infection control. J. R. Soc. Interface. 2009;6:727–736. doi: 10.1098/rsif.2009.0295.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.VanSciver M, Miller S, Hertzberg J. Particle image velocimetry of human cough. Aerosol Sci. Technol. 2011;45:415–422. doi: 10.1080/02786826.2010.542785. [DOI] [Google Scholar]
  • 54.Yan J, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. PNAS. 2018;115(5):1081–1086. doi: 10.1073/pnas.1716561115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ. Influenza virus aerosols in human exhaled breath: Particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9(3):e1003205. doi: 10.1371/journal.ppat.1003205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Yang W, Elankumaran S, Marr LC. Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes. J. R. Soc. Interface. 2011;8(61):1176–1184. doi: 10.1098/rsif.2010.0686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Tcharkhtchi A, et al. An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration. Bioactive Mater. 2020;6(1):106–122. doi: 10.1016/j.bioactmat.2020.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kulkarni H, et al. Evidence of respiratory syncytial virus spread by aerosol. Time to revisit infection control strategies? Am. J. Respir. Crit. Care Med. 2016;194:308–316. doi: 10.1164/rccm.201509-1833OC. [DOI] [PubMed] [Google Scholar]
  • 59.Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J. Infect. Dis. 2013;207(7):1037–1046. doi: 10.1093/infdis/jis773. [DOI] [PubMed] [Google Scholar]
  • 60.Tang JW, Kalliomaki P, Varila TM, Waris M, Koskela H. Nebulisers as a potential source of airborne virus. J. Infect. 2020;81(4):647–679. doi: 10.1016/j.jinf.2020.05.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Xie X, Li Y, Sun H, Liu L. Exhaled droplets due to talking and coughing. J. R. Soc. Interface. 2009;6:S703–714. doi: 10.1098/rsif.2009.0388.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information (663.4KB, docx)

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES